Pharma and Biotech (DLS30)

 0.00
   
  • 52 Week High: NULL
  • 52 Week Low: 0.00

Aptamer wins contract with 'top 10' repeat customer

By Benjamin Chiou

Date: Monday 13 Oct 2025

LONDON (ShareCast) - (Sharecast News) - Life sciences group Aptamer on Monday announced a new fee-for-service development contract with an unnamed top 10 global pharma company.
The contract, valued at £112,000, represents "success-based repeat business with an existing partner", Aptamer said.

It will focus on the development of Aptamer's Optimer binders against two protein targets to support the partner's internal biomarker research.

"This work paves the way for additional revenue for ELISA assay development and builds on our proven success with a top 5 pharma partner in this space," said chief executive Arron Tolley.

Shares were up 0.4% at 1.05p by 1035 BST.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are end of day values only.

 

Price Data

Price 0.00
Closing Price Change 0.00
% Change 0.00 %
--25 Close 0.00

Top Risers

Price Change
VRCI 0.90p +16.1%
GNS 2,650.00p +4.1%
GUN 0.16p +3.2%
SCLP 10.00p +2.6%
PRTC 133.00p +1.8%
AVCT 71.00p +1.4%
POLB 3.60p +1.4%
HLN 342.10p +1.0%
OXB 647.00p +0.6%
GSK 1,627.50p +0.2%

Top Fallers

Price Change
FUM 2.00p -14.9%
NFX 0.23p -13.2%
PRM 1.87p -8.4%
GENF 2.00p -6.5%
SAR 14.50p -6.5%
IMM 10.40p -6.3%
APTA 0.99p -5.7%
AGY 8.00p -5.3%
OPTI 9.75p -4.9%
SVNS 0.36p -4.1%

Top of Page